OP2 Drugs
🏢 View company profile →3Patents
3Active
3Granted
45Portfolio score
Filing activity: Mar 7, 2018 → May 13, 2020
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US11484529B2 | Desmethylanethole trithione derivatives for the treatment of diseases linked to mitochondrial reactive oxygen species (ROS) production | Chemistry; Metallurgy | 1 | Active |
| US11318113B2 | Compounds for the treatment of diseases linked to mitochondrial reactive oxygen species (ROS) production | Human Necessities | 1 | Active |
| US10653668B2 | Compounds for the treatment of diseases linked to mitochondrial reactive oxygen species (ROS) production | Human Necessities | 1 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.